South Centre Statement to the Fifty-Seventh Series of Meetings of the Assemblies of the Member States of WIPO
The South Centre is participating in the WIPO Assemblies being held from 2 to 11 October 2017 in Geneva. Read the South Centre statement here.
World running out of antibiotics, says WHO in new reports
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of August 2017.
Growing impetus to making AMR an integral issue in the 2030 Agenda for Sustainable Development
Access to and Benefit-Sharing of Marine Genetic Resources beyond National Jurisdiction: Developing a New Legally Binding Instrument
This paper examines the underlying principles and main elements of binding and non-binding international instruments relating to access and benefit-sharing of genetic resources. It discusses the gap left by the United Nations Convention on the Law of the Sea and some of the elements that might be considered in developing a new legally-binding instrument on access and benefit-sharing derived from the exploitation of marine genetic resources found in areas beyond national jurisdiction, as mandated by the United Nations General Assembly. (more…)
South Centre Statement at the 12th Session of the WIPO Advisory Committee on Enforcement (ACE)
In line with the mandate of the WIPO Development Agenda, WIPO must approach intellectual property enforcement in the context of broader societal interests and especially development-oriented concerns, in accordance with Article 7 of the TRIPS Agreement.
Antibiotic-resistant gonorrhea crisis: new drugs needed
State of discussion on AMR action, two years after the WHA Global Plan
Civil society and South Centre call for urgent actions to tackle AMR and ensure access and new innovation models
The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.
(Covering period: April – June 2017)
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of July 2017.
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines (revised)
Most free trade agreements (FTAs) signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization (WTO). (more…)
